Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Second filing announced for YM-905

Jan. 30, 2003

Kissei presents potent and selective beta3-adrenoceptor agonists for bladder dysfunction

Jan. 29, 2003

Nastech reacquires rights to intranasal product for sexual dysfunction

Jan. 28, 2003

Lilly Icos team discovers new tetracyclic PDE5 inhibitors

Jan. 27, 2003

PT-141 effective in ED patients who fail to respond to Viagra

Jan. 24, 2003

European launch of Cialis under way

Jan. 24, 2003

IPD-1151T licensed to Yamanouchi for global development in cystitis and prostatitis

Jan. 23, 2003

Potent, selective PDE5 inhibitors prepared and tested at Lilly Icos

Jan. 22, 2003

Long-term effects of tranilast in oligoasthenozoospermia

Jan. 20, 2003

Possible explanation for sildenafil-associated thrombotic conditions

Jan. 20, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...